NO20055495L - 4-(4-trans-hydroksysykloheksyl)amino-2-fenyl-7H-pyrrolo[2,3-d]-pyrimidinhydrogenmesylat og dets polymorfe former - Google Patents
4-(4-trans-hydroksysykloheksyl)amino-2-fenyl-7H-pyrrolo[2,3-d]-pyrimidinhydrogenmesylat og dets polymorfe formerInfo
- Publication number
- NO20055495L NO20055495L NO20055495A NO20055495A NO20055495L NO 20055495 L NO20055495 L NO 20055495L NO 20055495 A NO20055495 A NO 20055495A NO 20055495 A NO20055495 A NO 20055495A NO 20055495 L NO20055495 L NO 20055495L
- Authority
- NO
- Norway
- Prior art keywords
- pyrrolo
- trans
- phenyl
- amino
- cyclohexyl
- Prior art date
Links
- ZBTPHDQFPPDXPK-UHFFFAOYSA-N S(C)(=O)(=O)O.NC=1C2=C(N=C(N1)C1=CC=CC=C1)NC=C2 Chemical compound S(C)(=O)(=O)O.NC=1C2=C(N=C(N1)C1=CC=CC=C1)NC=C2 ZBTPHDQFPPDXPK-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46442203P | 2003-04-22 | 2003-04-22 | |
| EP03101093 | 2003-04-22 | ||
| PCT/EP2004/050573 WO2004094428A1 (en) | 2003-04-22 | 2004-04-21 | 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo`2, 3d! pyrimidine hydrogen mesylate and its polymorphic forms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20055495D0 NO20055495D0 (no) | 2005-11-21 |
| NO20055495L true NO20055495L (no) | 2006-01-23 |
Family
ID=36143550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055495A NO20055495L (no) | 2003-04-22 | 2005-11-21 | 4-(4-trans-hydroksysykloheksyl)amino-2-fenyl-7H-pyrrolo[2,3-d]-pyrimidinhydrogenmesylat og dets polymorfe former |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7381729B2 (uk) |
| EP (1) | EP1641797B1 (uk) |
| JP (1) | JP2006524214A (uk) |
| KR (1) | KR20060021296A (uk) |
| CN (1) | CN100360533C (uk) |
| AR (1) | AR043880A1 (uk) |
| AT (1) | ATE373002T1 (uk) |
| AU (1) | AU2004232495B2 (uk) |
| BR (1) | BRPI0409511A (uk) |
| CA (1) | CA2522810A1 (uk) |
| DE (1) | DE602004008919T2 (uk) |
| DK (1) | DK1641797T3 (uk) |
| ES (1) | ES2290696T3 (uk) |
| IL (1) | IL171120A (uk) |
| MX (1) | MXPA05011348A (uk) |
| NO (1) | NO20055495L (uk) |
| PL (1) | PL1641797T3 (uk) |
| PT (1) | PT1641797E (uk) |
| RU (1) | RU2345994C2 (uk) |
| SA (1) | SA04250093B1 (uk) |
| SI (1) | SI1641797T1 (uk) |
| TW (1) | TWI324517B (uk) |
| UA (1) | UA81806C2 (uk) |
| WO (1) | WO2004094428A1 (uk) |
| ZA (1) | ZA200508519B (uk) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR043880A1 (es) | 2003-04-22 | 2005-08-17 | Solvay Pharm Gmbh | Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas |
| WO2007073855A1 (en) * | 2005-12-23 | 2007-07-05 | Bayer Healthcare Ag | Use of adenosine a1 receptor agonists for the protection of renal cells against toxic effects caused by aminoglycosides during treatment of infectious diseases |
| TW200808819A (en) * | 2006-06-19 | 2008-02-16 | Solvay Pharm Gmbh | Use of adenosine A1 antagonists in radiocontrast media induced nephrophaty |
| CN103724339B (zh) * | 2012-09-27 | 2015-10-14 | 广东东阳光药业有限公司 | 二氢嘧啶衍生物的晶型 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE55646B1 (en) * | 1982-08-19 | 1990-12-05 | Warner Lambert Co | 3-deazaguanine sulfonic acid salts |
| CS249455B1 (en) * | 1985-01-24 | 1987-03-12 | Miroslav Protiva | N-substituted 2-chloro-7-fluoro-10-piperazino-10,11-dihydrodibenzo(b,f)thiepines and their salts and method of their preparation |
| JP2815691B2 (ja) * | 1990-09-20 | 1998-10-27 | 麒麟麦酒株式会社 | Ｋｒｎ２３９１酸付加塩およびその用途 |
| WO1994013676A1 (en) * | 1992-12-17 | 1994-06-23 | Pfizer Inc. | Pyrrolopyrimidines as crf antagonists |
| FR2708604B1 (fr) * | 1993-07-30 | 1995-10-20 | Sanofi Elf | Utilisation de dérivés de benzènesulfonyl-indole pour la préparation de médicaments. |
| JPH08198876A (ja) * | 1995-01-30 | 1996-08-06 | Yoshitomi Pharmaceut Ind Ltd | トランス−Ｎ−（１Ｈ−ピラゾロ〔３，４−ｂ〕ピリジン−４−イル）−４−グアニジノメチルシクロヘキサンカルボキサミド・１メタンスルホン酸塩・１水和物 |
| JPH08337584A (ja) * | 1995-04-10 | 1996-12-24 | Dai Ichi Seiyaku Co Ltd | 縮合六環式アミノ化合物、これを含有する医薬及びその製法 |
| FR2749846B1 (fr) * | 1996-06-17 | 1998-09-11 | Pf Medicament | Sel de methanesulfonate d'une arylpiperazine derivee de tryptamine et ses solvates pour usage pharmaceutique |
| MA24500A1 (fr) * | 1997-03-21 | 1998-10-01 | Lg Life Sciences Ltd | Derive du sel d'acide carboxylique de naphthyridine . |
| WO1999062518A1 (en) * | 1998-06-02 | 1999-12-09 | Osi Pharmaceuticals, Inc. | PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE |
| US6878716B1 (en) * | 1998-06-02 | 2005-04-12 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptor and uses thereof |
| TWI223598B (en) * | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
| AU784878B2 (en) * | 1999-12-02 | 2006-07-13 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 A2A and A3 receptors and uses thereof |
| ATE253570T1 (de) * | 2000-03-03 | 2003-11-15 | Pfizer | 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1, , 3,4-tetrahydroisochinol-2-yl)-5-(2- pyridyl)chinazoline mesylat und polymorphs |
| WO2002032861A2 (en) * | 2000-10-17 | 2002-04-25 | Merck & Co., Inc. | Orally active salts with tyrosine kinase activity |
| US6680324B2 (en) * | 2000-12-01 | 2004-01-20 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptors and uses thereof |
| US6673802B2 (en) * | 2000-12-01 | 2004-01-06 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| AR043880A1 (es) | 2003-04-22 | 2005-08-17 | Solvay Pharm Gmbh | Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas |
-
2004
- 2004-04-19 AR ARP040101306A patent/AR043880A1/es unknown
- 2004-04-20 TW TW093110973A patent/TWI324517B/zh not_active IP Right Cessation
- 2004-04-21 EP EP04728571A patent/EP1641797B1/en not_active Expired - Lifetime
- 2004-04-21 DE DE602004008919T patent/DE602004008919T2/de not_active Expired - Lifetime
- 2004-04-21 AU AU2004232495A patent/AU2004232495B2/en not_active Ceased
- 2004-04-21 ES ES04728571T patent/ES2290696T3/es not_active Expired - Lifetime
- 2004-04-21 UA UAA200511088A patent/UA81806C2/uk unknown
- 2004-04-21 KR KR1020057019944A patent/KR20060021296A/ko not_active Ceased
- 2004-04-21 PL PL04728571T patent/PL1641797T3/pl unknown
- 2004-04-21 WO PCT/EP2004/050573 patent/WO2004094428A1/en not_active Ceased
- 2004-04-21 AT AT04728571T patent/ATE373002T1/de active
- 2004-04-21 DK DK04728571T patent/DK1641797T3/da active
- 2004-04-21 CN CNB2004800106903A patent/CN100360533C/zh not_active Expired - Fee Related
- 2004-04-21 SI SI200430470T patent/SI1641797T1/sl unknown
- 2004-04-21 RU RU2005136215/04A patent/RU2345994C2/ru not_active IP Right Cessation
- 2004-04-21 CA CA002522810A patent/CA2522810A1/en not_active Abandoned
- 2004-04-21 JP JP2006505565A patent/JP2006524214A/ja active Pending
- 2004-04-21 PT PT04728571T patent/PT1641797E/pt unknown
- 2004-04-21 BR BRPI0409511-1A patent/BRPI0409511A/pt not_active IP Right Cessation
- 2004-04-21 MX MXPA05011348A patent/MXPA05011348A/es active IP Right Grant
- 2004-04-21 US US10/828,650 patent/US7381729B2/en not_active Expired - Fee Related
- 2004-04-22 SA SA4250093A patent/SA04250093B1/ar unknown
-
2005
- 2005-09-27 IL IL171120A patent/IL171120A/en not_active IP Right Cessation
- 2005-10-20 ZA ZA200508519A patent/ZA200508519B/en unknown
- 2005-11-21 NO NO20055495A patent/NO20055495L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1641797A1 (en) | 2006-04-05 |
| EP1641797B1 (en) | 2007-09-12 |
| CN1777606A (zh) | 2006-05-24 |
| RU2345994C2 (ru) | 2009-02-10 |
| AU2004232495B2 (en) | 2010-04-22 |
| SI1641797T1 (sl) | 2007-12-31 |
| DE602004008919D1 (de) | 2007-10-25 |
| NO20055495D0 (no) | 2005-11-21 |
| AR043880A1 (es) | 2005-08-17 |
| TWI324517B (en) | 2010-05-11 |
| ATE373002T1 (de) | 2007-09-15 |
| US20040248912A1 (en) | 2004-12-09 |
| JP2006524214A (ja) | 2006-10-26 |
| BRPI0409511A (pt) | 2006-04-18 |
| TW200505457A (en) | 2005-02-16 |
| AU2004232495A1 (en) | 2004-11-04 |
| DE602004008919T2 (de) | 2008-06-19 |
| PL1641797T3 (pl) | 2008-01-31 |
| CA2522810A1 (en) | 2004-11-04 |
| US7381729B2 (en) | 2008-06-03 |
| IL171120A (en) | 2011-01-31 |
| ES2290696T3 (es) | 2008-02-16 |
| WO2004094428A1 (en) | 2004-11-04 |
| CN100360533C (zh) | 2008-01-09 |
| SA04250093B1 (ar) | 2008-07-12 |
| ZA200508519B (en) | 2007-04-25 |
| HK1089767A1 (en) | 2006-12-08 |
| UA81806C2 (uk) | 2008-02-11 |
| PT1641797E (pt) | 2007-12-21 |
| KR20060021296A (ko) | 2006-03-07 |
| RU2005136215A (ru) | 2006-03-20 |
| MXPA05011348A (es) | 2005-11-28 |
| DK1641797T3 (da) | 2007-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02012795A (es) | Carvedilol. | |
| IL172357A0 (en) | Method for the production of substituted 3-aryl-butyl amine compounds | |
| DE60218703D1 (de) | (-)-1-(3,4-dichlorphenyl)-3-azabicyclo ä3.1.0ühexan, zusammensetzungen davon und verwendung als dopamin-wiederaufnahme-hemmer | |
| MXPA04003007A (es) | Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades. | |
| CL2010000204A1 (es) | Compuestos intermediarios derivados de 4 amino-3-metoxibenzamida; compuesto intermediario n-{4-[4-(ciclopropilmetil)piperazin-1-il]ciclohexil}acetamida; compuesto intermediario 2-cloro-7-etil-7,8-dihidro-5-metil-8-(1-metiletil)-6(5h)-pteridinona, útiles en la preparación de dihidropteridinonas sustituidas (divisional sol. 2077-05). | |
| EA200400491A1 (ru) | Полиморфная форма римонабанта, способ её получения и содержащие её фармацевтические композиции | |
| TW200624421A (en) | Method for preparing n-phenylpyrazole-1-carboxamides | |
| MXPA05013474A (es) | Derivados de quinolilamida como antagonistas de ccr-5. | |
| PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
| TW200420541A (en) | Crystalline forms | |
| EA200600485A1 (ru) | Способ получения производных 2-оксо-1-пирролидина | |
| YU61103A (sh) | Postupci za produkciju supstituisanih 2-(2-piridilmetil) sulfinil-1h-benzimidazola | |
| HRP20080057T3 (en) | 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof | |
| MY157375A (en) | Novel crystalline forms of <2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl>-(2-chlorophenyl)-methanone | |
| CY1105039T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΝΩΣΕΙΣ ΒΕΝΖΟ[b]ΑΖΕΠΙΝ-2-ΟΝΗΣ | |
| TR200503401T1 (tr) | Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları | |
| NO20055495L (no) | 4-(4-trans-hydroksysykloheksyl)amino-2-fenyl-7H-pyrrolo[2,3-d]-pyrimidinhydrogenmesylat og dets polymorfe former | |
| MXPA04005305A (es) | Nuevo polimorfo cristalino de clorhidrato de venlafaxina y metodos para preparacion del mismo. | |
| NO20056238L (no) | Forbedrede mater for fremstilling av Alfa-Polymorfisk Eletriptanhydrobromid | |
| NO20043988L (no) | Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner | |
| MXPA05013649A (es) | Fluorbutenos nematicidas que contienen tiazolina. | |
| EA200300771A1 (ru) | Новая соль бензоилгуанидина | |
| NO20052197L (no) | Fremgangsmate for fremstilling av pyrazol | |
| ITRM20010309A1 (it) | Procedimento per la produzione di composti perfluoro-organici mediante florurazione elettrochimica. | |
| FR2854402A1 (fr) | Nouveau procede et intermediaires de preparation de composes 19-nor-steroides |